50 results on '"Ruggieri, Maddalena"'
Search Results
2. Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis
Catalog
Books, media, physical & digital resources
3. Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort
4. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis
5. Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study
6. Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance
7. The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis
8. IFNβ enhances mesenchymal stromal (Stem) cells immunomodulatory function through STAT1-3 activation and mTOR-associated promotion of glucose metabolism
9. Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients
10. Autophagy increase in Merosin-Deficient Congenital Muscular Dystrophy type 1A.
11. Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis
12. Identification of Two Major Conformational Aquaporin-4 Epitopes for Neuromyelitis Optica Autoantibody Binding
13. The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006)
14. Neurofilament ELISA validation
15. Serum neurofilament light chain in a cohort of multiple sclerosis, MOG-antibody diseases and neuromyelitis optica spectrum disorders patients
16. King's progression rate: Prognostic value in amyotrophic lateral sclerosis according to cerebrospinal neurofilament light chain levels
17. Serum Neurofilament Light Chain Levels and Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Acquired Demyelinating Syndromes
18. B and T Immunoregulation: A New Insight of B Regulatory Lymphocytes in Autism Spectrum Disorder
19. Serum levels of N-acetyl-aspartate in migraine and tension-type headache
20. Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients
21. Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients
22. Serum levels of N-acetylaspartate in Huntingtonʼs disease: Preliminary results
23. Is cerebrospinal fluid amyloid‐β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients?
24. Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
25. Serum N -acetylaspartate Level in Amyotrophic Lateral Sclerosis
26. Age-related changes of serum N-acetyl-aspartate in healthy controls
27. Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics
28. Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy
29. PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels
30. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies
31. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes
32. LFA-1 expression on CD4 +CD45RO + peripheral blood T-lymphocytes in RR MS: effects induced by rIFNβ-1a
33. Host-Cell Type Dependent Features of Recombinant Human Aquaporin-4 Orthogonal Arrays of Particles—New Insights for Structural and Functional Studies
34. Neuroblastoma cell line and lymphocytes talk for cladribine influenced apoptosis and inflammation pathways in multiple sclerosis (MS): an “in vitro” study
35. Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD)
36. Cerebrospinal fluid analysis and the determination of oligoclonal bands
37. Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis
38. Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.
39. Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection
40. Cerebrospinal fluid Osteopontin and Neurofilament levels mark different patterns of brain atrophy in Clinically Isolated Syndrome (P5.218)
41. CSF Neurofilament Light Chain Predicts Evolution to MS in Clinically Isolated Syndromes (P1.230)
42. Neurofilament ELISA validation.
43. Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity
44. Serum levels of N‐acetylaspartate in Huntington's disease: Preliminary results
45. Glatiramer Acetate in Multiple Sclerosis: A Review
46. LFA-1 expression on CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: effects induced by rIFNβ-1a
47. Serum levels of N-acetyl-aspartate in migraine and tension-type headache.
48. Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics.
49. Plasma neurofilament light chain in fibromyalgia: A case control study exploring correlation with clinical and cognitive features.
50. Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.